What was the overall market valuation of the UK softgel capsule market in 2024?

The overall market valuation was $173.22 Million in 2024. Read More

What is the projected market valuation for the UK softgel capsule market by 2035?

The projected valuation for 2035 is $308.3 Million. Read More

What is the expected CAGR for the UK softgel capsule market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 5.38%. Read More

Which application segment had the highest valuation in 2024?

The Pharmaceuticals segment had the highest valuation at $50.0 - $100.0 Million in 2024. Read More

What are the key players in the UK softgel capsule market?

Key players include Catalent, Amway, BASF, FMC Corporation, Lonza, Evonik Industries, Aenova Group, Soft Gel Technologies, and Natural Alternatives International. Read More

Which distribution channel is projected to perform best in the UK softgel capsule market?

Pharmacies are projected to perform best, with a valuation range of $50.0 - $90.0 Million. Read More

What is the valuation range for the Gelatin ingredient segment in 2024?

The valuation range for the Gelatin ingredient segment was $40.0 - $70.0 Million in 2024. Read More

How does the valuation of the Vitamins segment compare to the Dietary Supplements segment in 2024?

The Vitamins segment had a valuation range of $40.0 - $70.0 Million, while the Dietary Supplements segment ranged from $33.22 - $38.3 Million. Read More

What formulation type is expected to have the highest valuation in the UK softgel capsule market?

The Gelled formulation type is expected to have the highest valuation, ranging from $58.22 - $93.3 Million. Read More

What is the valuation range for the Vegetable Gelatin ingredient segment in 2024?

The valuation range for the Vegetable Gelatin ingredient segment was $20.0 - $40.0 Million in 2024. Read More

UK Softgel Capsule Market

ID: MRFR/Pharma/47923-HCR

200 Pages

Vikita Thakur

Last Updated: April 06, 2026

UK Softgel Capsule Market Research Report By Type (Gelatin Type, Non-Animal Type) and By Application (Vitamins, Supplement, Nutrition) -Forecast to 2035

UK Softgel Capsule Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)5.38%

2024 Market Size$ 173.22 Million

2025 Market Size$ 182.54 Million

2035 Market Size$ 308.3 Million

Key Players

Catalent

Amway

BASF

FMC Corporation

Lonza

Evonik Industries

Trends

Rising Demand for Dietary Supplements
Technological Advancements in Production
Focus on Personalized Nutrition

Opportunities

Increasing Health Awareness
Expansion of E-commerce Platforms
Regulatory Support for Nutraceuticals

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Application (USD Million)
  1. 4.1.1 Nutraceuticals
  2. 4.1.2 Pharmaceuticals
  3. 4.1.3 Cosmetics
  4. 4.1.4 Vitamins
  5. 4.1.5 Dietary Supplements
2. 4.2 Pharmaceutical, BY Ingredients (USD Million)
  1. 4.2.1 Gelatin
  2. 4.2.2 Fish Gelatin
  3. 4.2.3 Vegetable Gelatin
  4. 4.2.4 Active Ingredients
  5. 4.2.5 Colorants
3. 4.3 Pharmaceutical, BY Formulation (USD Million)
  1. 4.3.1 Single Phase
  2. 4.3.2 Multi-Phase
  3. 4.3.3 Emulsified
  4. 4.3.4 Suspended
  5. 4.3.5 Gelled
4. 4.4 Pharmaceutical, BY Distribution Channel (USD Million)
  1. 4.4.1 Online Retail
  2. 4.4.2 Pharmacies
  3. 4.4.3 Health Stores
  4. 4.4.4 Supermarkets
  5. 4.4.5 Direct Sales
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Catalent (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Amway (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 BASF (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 FMC Corporation (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Lonza (CH)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Evonik Industries (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Aenova Group (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Soft Gel Technologies (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Natural Alternatives International (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY APPLICATION
3. 6.3 UK MARKET ANALYSIS BY INGREDIENTS
4. 6.4 UK MARKET ANALYSIS BY FORMULATION
5. 6.5 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY INGREDIENTS, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY INGREDIENTS, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY FORMULATION, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY FORMULATION, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY INGREDIENTS, 2025-2035 (USD Million)
  3. 7.2.3 BY FORMULATION, 2025-2035 (USD Million)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK UK Softgel Capsule Market Segmentation

UK Softgel Capsule Market By Application (USD Million, 2025-2035)

Nutraceuticals
UK Softgel Capsule Markets
Cosmetics
Vitamins
Dietary Supplements

UK Softgel Capsule Market By Ingredients (USD Million, 2025-2035)

Gelatin
Fish Gelatin
Vegetable Gelatin
Active Ingredients
Colorants

UK Softgel Capsule Market By Formulation (USD Million, 2025-2035)

Single Phase
Multi-Phase
Emulsified
Suspended
Gelled

UK Softgel Capsule Market By Distribution Channel (USD Million, 2025-2035)

Online Retail
Pharmacies
Health Stores
Supermarkets
Direct Sales

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”